189 related articles for article (PubMed ID: 9790164)
1. Olanzapine augmentation of fluoxetine in the treatment of refractory obsessive-compulsive disorder.
Potenza MN; Wasylink S; Longhurst JG; Epperson CN; McDougle CJ
J Clin Psychopharmacol; 1998 Oct; 18(5):423-4. PubMed ID: 9790164
[No Abstract] [Full Text] [Related]
2. Olanzapine augmentation of serotonin uptake inhibitors in obsessive-compulsive disorder: an open study.
Francobandiera G
Can J Psychiatry; 2001 May; 46(4):356-8. PubMed ID: 11387793
[TBL] [Abstract][Full Text] [Related]
3. Olanzapine augmentation for treatment-resistant obsessive-compulsive disorder.
Koran LM; Ringold AL; Elliott MA
J Clin Psychiatry; 2000 Jul; 61(7):514-7. PubMed ID: 10937610
[TBL] [Abstract][Full Text] [Related]
4. A double-blind, placebo-controlled trial of olanzapine addition in fluoxetine-refractory obsessive-compulsive disorder.
Shapira NA; Ward HE; Mandoki M; Murphy TK; Yang MC; Blier P; Goodman WK
Biol Psychiatry; 2004 Mar; 55(5):553-5. PubMed ID: 15023585
[TBL] [Abstract][Full Text] [Related]
5. Olanzapine addition in obsessive-compulsive disorder refractory to selective serotonin reuptake inhibitors: an open-label case series.
Weiss EL; Potenza MN; McDougle CJ; Epperson CN
J Clin Psychiatry; 1999 Aug; 60(8):524-7. PubMed ID: 10485634
[TBL] [Abstract][Full Text] [Related]
6. Fluoxetine Adjunctive Therapy for Obsessive-Compulsive Symptoms Associated With Olanzapine in Schizophrenic Patients.
Figueiredo T; Segenreich D; Mattos P
J Clin Psychopharmacol; 2016 Aug; 36(4):389-91. PubMed ID: 27285659
[No Abstract] [Full Text] [Related]
7. Olanzapine augmentation of fluvoxamine-refractory obsessive-compulsive disorder (OCD): a 12-week open trial.
Bogetto F; Bellino S; Vaschetto P; Ziero S
Psychiatry Res; 2000 Oct; 96(2):91-8. PubMed ID: 11063782
[TBL] [Abstract][Full Text] [Related]
8. Serotonin and dopamine antagonism in obsessive-compulsive disorder: effect of atypical antipsychotic drugs.
Ramasubbu R; Ravindran A; Lapierre Y
Pharmacopsychiatry; 2000 Nov; 33(6):236-8. PubMed ID: 11147933
[TBL] [Abstract][Full Text] [Related]
9. Antidepressant augmentation with low-dose olanzapine in obsessive-compulsive disorder.
Marusic A; Farmer A
Br J Psychiatry; 2000 Dec; 177():567. PubMed ID: 11270368
[No Abstract] [Full Text] [Related]
10. Effectiveness of olanzapine treatment for severe obsessive-compulsive disorder.
Marazziti D; Pallanti S
Am J Psychiatry; 1999 Nov; 156(11):1834-5. PubMed ID: 10553756
[No Abstract] [Full Text] [Related]
11. Open-label olanzapine in obsessive-compulsive disorder refractory to antidepressant treatment.
Crocq MA; Leclercq P; Guillon MS; Bailey PE
Eur Psychiatry; 2002 Sep; 17(5):296-7. PubMed ID: 12381502
[No Abstract] [Full Text] [Related]
12. Olanzapine-sertraline combination in schizophrenia with obsessive-compulsive disorder.
Poyurovsky M; Kurs R; Weizman A
J Clin Psychiatry; 2003 May; 64(5):611. PubMed ID: 12755669
[No Abstract] [Full Text] [Related]
13. Influence of fluoxetine on olanzapine pharmacokinetics.
Gossen D; de Suray JM; Vandenhende F; Onkelinx C; Gangji D
AAPS PharmSci; 2002; 4(2):E11. PubMed ID: 12102620
[TBL] [Abstract][Full Text] [Related]
14. Olanzapine augmentation of paroxetine-refractory obsessive-compulsive disorder.
D'Amico G; Cedro C; Muscatello MR; Pandolfo G; Di Rosa AE; Zoccali R; La Torre D; D'Arrigo C; Spina E
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Jun; 27(4):619-23. PubMed ID: 12787848
[TBL] [Abstract][Full Text] [Related]
15. A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder.
Bloch MH; Landeros-Weisenberger A; Kelmendi B; Coric V; Bracken MB; Leckman JF
Mol Psychiatry; 2006 Jul; 11(7):622-32. PubMed ID: 16585942
[TBL] [Abstract][Full Text] [Related]
16. A long-term trial of the effectiveness and safety of atypical antipsychotic agents in augmenting SSRI-refractory obsessive-compulsive disorder.
Matsunaga H; Nagata T; Hayashida K; Ohya K; Kiriike N; Stein DJ
J Clin Psychiatry; 2009 Jun; 70(6):863-8. PubMed ID: 19422759
[TBL] [Abstract][Full Text] [Related]
17. [Augmentation of selective serotonin reuptake inhibitors (SSRI) with atypical antipsychotics in the treatment of depression].
Weimer E; Braus DF; Cavus I; Thome J
Fortschr Neurol Psychiatr; 2002 Apr; 70(4):210-7. PubMed ID: 11948436
[TBL] [Abstract][Full Text] [Related]
18. Fluoxetine augmentation with olanzapine for treatment of chronic resistant depression in an elderly patient: a case report.
Detweiler MB; Trinkle DB
J Clin Psychiatry; 2003 Jul; 64(7):851-2. PubMed ID: 12934994
[No Abstract] [Full Text] [Related]
19. Risperidone augmentation of specific serotonin reuptake inhibitors in the treatment of refractory obsessive-compulsive disorder: report of two cases.
Sun TF; Lin PY; Wu CK
Chang Gung Med J; 2001 Sep; 24(9):587-92. PubMed ID: 11725630
[TBL] [Abstract][Full Text] [Related]
20. Olanzapine augmentation of fluoxetine in the treatment of trichotillomania.
Potenza MN; Wasylink S; Epperson CN; McDougle CJ
Am J Psychiatry; 1998 Sep; 155(9):1299-300. PubMed ID: 9734562
[No Abstract] [Full Text] [Related]
[Next] [New Search]
